Cancer tissue

Colorectal cancer patients with rare mutations to benefit from life-extending treatment

NICE recommends pembrolizumab for colorectal cancer patients with rare mutations

Read news story

Blogs

NICE Talks podcasts

NICE Talks brings you the real life experiences of people working within the NHS, public health and social care.

You will hear the stories behind our work to improve care across the country through evidence-based guidance.

Press and media

Contact the press office: 07973 970 534 | pressoffice@nice.org.uk